K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Johann S. de Bono
also known as Ari Vanderwalde, De Bono, J, De Bono, J.
Royal Marsden NHS Foundation Trust · Institute of Cancer Research · Cancer Research UK · Royal Marsden Hospital
About this author
Works
2,436
Cited by
134,951
h-index
161
i10
791
ORCID ↗
Top papers
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher, Karim Fizazi, Fred Saad, et al.
·
2012
·
New England Journal of Medicine
↗ 4,554
OA
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. de Bono, Christopher J. Logothetis, Arturo Molina, et al.
·
2011
·
New England Journal of Medicine
↗ 4,377
OA
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan R. Robinson, Eliezer M. Van Allen, Yi-Mi Wu, et al.
·
2015
·
Cell
↗ 3,620
OA
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers
Peter C.C. Fong, David S. Boss, Timothy A. Yap, et al.
·
2009
·
New England Journal of Medicine
↗ 3,620
OA
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann S. de Bono, Stéphane Oudard, Mustafa Özgüroğlu, et al.
·
2010
·
The Lancet
↗ 3,274
Pan-cancer analysis of whole genomes
Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, et al.
·
2020
·
Nature
↗ 3,240
OA
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf, et al.
·
2014
·
New England Journal of Medicine
↗ 3,013
OA
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan, Matthew R. Smith, Johann S. de Bono, et al.
·
2012
·
New England Journal of Medicine
↗ 2,776
OA
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
Oliver Sartor, Johann S. de Bono, Kim N., et al.
·
2021
·
New England Journal of Medicine
↗ 2,475
OA
Olaparib for Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono, Joaquı́n Mateo, Karim Fizazi, et al.
·
2020
·
New England Journal of Medicine
↗ 2,200
OA
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono, Howard I. Scher, Bruce Montgomery, et al.
·
2008
·
Clinical Cancer Research
↗ 2,178
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
Joaquı́n Mateo, Suzanne Carreira, Shahneen Sandhu, et al.
·
2015
·
New England Journal of Medicine
↗ 2,173
OA